Completed PHASE4 INTERVENTIONAL 2-arm NCT03261466

BIFI-OBESE: Clinical Trial in Paediatric Obesity (BIFI-OBESE)

BIFI-OBESE: Effect of Probiotic Bifidobacterium Breve BR03 and Bifidobacterium Breve B632 in Paediatric Obesity

Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita

Interventions Bifidobacterium breve BR03 and Bifidobacterium breve B632 Placebos

Updated 6 times since 2017 Last updated: Jan 10, 2018 Started: Nov 20, 2013 Primary completion: Oct 30, 2017 Completion: Oct 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obesity, Childhood, this trial is completed. The trial is conducted by Azienda Ospedaliero Universitaria Maggiore della Carita and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

Sep 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliero Universitaria Maggiore della Carita

Data source: Azienda Ospedaliero Universitaria Maggiore della Carita

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Novara, Italy